Corticosteroids are the most well-established drugs linked to cataract formation, but they’re not the only ones. Several medication classes, from certain antipsychotics to common diuretics, can cloud the lens of the eye over months or years of use. The risk depends heavily on the drug, the dose, and how long you take it.
Corticosteroids Carry the Highest Risk
Corticosteroids (prednisone, dexamethasone, prednisolone, and others) are the drugs most strongly tied to cataracts. They cause a specific type called a posterior subcapsular cataract, which forms at the back center of the lens and tends to interfere with reading and bright-light vision earlier than other cataract types. Chronic use leads to these opacities in roughly 36% of patients, though the rate varies widely depending on dose and duration.
The relationship is dose-dependent. The key factors are cumulative dose, treatment duration beyond six months, and how the drug is delivered. Oral corticosteroids carry the greatest risk, followed by topical eye drops, then injections around the eye. In studies of children on long-term oral prednisone for kidney disease, about 18% developed cataracts after a median of 4.3 years, and those who developed cataracts had received nearly double the cumulative dose of those who didn’t. Adults on dexamethasone for blood cancers developed cataracts even faster: 36% within six treatment cycles.
Inhaled corticosteroids for asthma and COPD also pose a risk, especially at higher doses. In COPD patients, the overall cataract rate was about 16%, but among those using high-dose inhalers for more than a year, the rate climbed to nearly 40%. Even a single injection of a steroid around the eye (used for inflammatory eye conditions) carries a small risk of around 1.7%.
Corticosteroids damage the lens through several pathways. They trigger oxidative stress, disrupt the normal balance of sodium and potassium in lens cells, and cause the cells lining the lens to migrate abnormally toward the back of the capsule, where they pile up and create the characteristic opacity.
Quetiapine and Other Antipsychotics
Quetiapine (Seroquel) is one of the few non-steroid drugs with a specific FDA warning about cataracts. The drug’s prescribing label recommends a lens examination at the start of treatment and every six months during ongoing use. This guidance stems from animal studies that found lens changes, and the FDA considers the risk significant enough to warrant routine monitoring even though large-scale human data is still limited.
Other antipsychotic medications, particularly older ones like chlorpromazine, have also been associated with lens deposits and opacities, though quetiapine is the one that carries the most explicit monitoring requirement today.
Photosensitizing Medications and Sunlight
A surprising category of drugs doesn’t damage the lens directly but appears to amplify the cataract-causing effects of sunlight. These are called photosensitizing medications, and a long-running population study (the Beaver Dam Eye Study) found evidence that ultraviolet B exposure and use of these drugs interact to increase the risk of cortical cataracts, the type that forms around the edges of the lens.
The drugs flagged in this research span several common classes:
- Diuretics: hydrochlorothiazide, furosemide
- Diabetes medications: glyburide
- Antidepressants: amitriptyline, paroxetine, sertraline
- Antibiotics: tetracycline, sulfamethoxazole, trimethoprim, ciprofloxacin
- Heart medications: amiodarone
- Pain relievers: naproxen
The risk from any single photosensitizing drug is modest on its own. It appears to matter most in combination with significant sun exposure over years. If you take one of these medications long-term, wearing UV-blocking sunglasses outdoors is a practical way to reduce the added risk.
Amiodarone
Amiodarone, a heart rhythm medication, deserves its own mention because it causes visible lens deposits in 50 to 60% of patients. It also causes corneal deposits in 70 to 100% of users, which can produce the symptom of seeing colored halos around lights. However, there’s an important distinction: neither the lens nor corneal deposits from amiodarone typically impair vision, and their presence alone is not a reason to stop the drug. The deposits tend to increase with higher doses and longer treatment but remain visually insignificant for most people.
SSRIs and Serotonin Levels
Selective serotonin reuptake inhibitors, the most commonly prescribed antidepressants, have drawn attention as a potential cataract risk. The theory centers on serotonin itself. Elevated serotonin levels have been detected in the fluid inside the eye of cataract surgery patients, and in animal studies, applying serotonin directly to rat eyes caused rapid, dense cataracts. SSRIs like fluoxetine, sertraline, citalopram, escitalopram, and fluvoxamine work by raising serotonin levels, which could theoretically affect the lens. The evidence in humans is still early, but the biological plausibility has prompted ongoing investigation.
Statins: Probably Not a Real Risk
Cholesterol-lowering statins have generated concern because the lens needs cholesterol maintained within a narrow range to stay clear. Some observational studies initially suggested a link. A large meta-analysis published in the Journal of the American Heart Association found that cohort studies showed a 13% increase in cataract risk among statin users. But when the researchers looked at more rigorous study designs (case-control studies and randomized controlled trials), no increased risk appeared. The authors concluded there is no clear evidence that statins cause cataracts. The association seen in observational studies likely reflects other factors, such as the age and health profile of people who take statins.
Can Drug-Induced Cataracts Be Reversed?
In early or mild cases, drug-induced cataracts can sometimes be reversed, or at least their progression halted, if the medication responsible is identified and stopped promptly. This is more likely with newer, less dense opacities. Once a cataract has matured and significantly clouded the lens, the damage is permanent and the only treatment is surgical lens replacement, the same procedure used for age-related cataracts.
The practical takeaway is timing. If you’re on a long-term medication known to affect the lens, periodic eye exams give you the best chance of catching changes early, when adjusting the drug might still make a difference. For corticosteroids specifically, your doctor may be able to reduce the dose, switch to a different delivery method, or explore steroid-sparing alternatives if early lens changes appear.